BioInvent International Management
Management criteria checks 4/4
BioInvent International's CEO is Martin Welschof, appointed in Sep 2018, has a tenure of 4.42 years. total yearly compensation is SEK4.75M, comprised of 56.9% salary and 43.1% bonuses, including company stock and options. directly owns 0.034% of the company’s shares, worth SEK705.59K. The average tenure of the management team and the board of directors is 4.4 years and 5.6 years respectively.
Key information
Martin Welschof
Chief executive officer
kr4.7m
Total compensation
| CEO salary percentage | 56.9% |
| CEO tenure | 4.4yrs |
| CEO ownership | 0.03% |
| Management average tenure | 4.4yrs |
| Board average tenure | 5.6yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2022 | n/a | n/a | -kr43m |
| Jun 30 2022 | n/a | n/a | -kr42m |
| Mar 31 2022 | n/a | n/a | -kr266m |
| Dec 31 2021 | kr5m | kr3m | -kr278m |
| Sep 30 2021 | n/a | n/a | -kr171m |
| Jun 30 2021 | n/a | n/a | -kr141m |
| Mar 31 2021 | n/a | n/a | -kr123m |
| Dec 31 2020 | kr5m | kr3m | -kr76m |
| Sep 30 2020 | n/a | n/a | -kr146m |
| Jun 30 2020 | n/a | n/a | -kr150m |
| Mar 31 2020 | n/a | n/a | -kr144m |
| Dec 31 2019 | kr4m | kr2m | -kr139m |
| Sep 30 2019 | n/a | n/a | -kr130m |
| Jun 30 2019 | n/a | n/a | -kr116m |
| Mar 31 2019 | n/a | n/a | -kr126m |
| Dec 31 2018 | kr3m | kr800k | -kr123m |
Compensation vs Market: Martin's total compensation ($USD448.66K) is below average for companies of similar size in the UK market ($USD745.84K).
Compensation vs Earnings: Martin's compensation has been consistent with company performance over the past year.
CEO
Martin Welschof (61 yo)
4.4yrs
Tenure
kr4,747,000
Compensation
Dr. Martin Welschof, Ph D has been the Chief Executive Officer of Opsona Therapeutics Limited since February 2012. Dr. Welschof has been Chief Executive Officer at BioInvent Intl AB (publ) since 2018.He i...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President & CEO | 4.4yrs | kr4.75m | 0.034% SEK 705.6k | |
| Chief Financial Officer | 7.1yrs | no data | 0.012% SEK 252.1k | |
| Chief Operating Officer | less than a year | no data | no data | |
| Senior Vice President of Technical Operations | 6.4yrs | no data | 0.034% SEK 702.5k | |
| Chief Scientific Officer | no data | kr2.35m | 0.035% SEK 727.4k | |
| Senior Director of Investor Relations | 2yrs | no data | no data | |
| Chief Medical Officer | 6.1yrs | no data | 0.0046% SEK 94.7k | |
| Head of Preclinical Research | no data | no data | no data | |
| Chief Business Officer | less than a year | no data | no data |
4.4yrs
Average Tenure
57yo
Average Age
Experienced Management: BINVS's management team is considered experienced (4.4 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Independent Director | 5.1yrs | kr420.00k | 0.046% SEK 945.0k | |
| Independent Chairman of the Board | 5.1yrs | kr682.00k | 0.027% SEK 552.4k | |
| Independent Director | 2.6yrs | kr360.00k | no data | |
| Independent Director | 1.8yrs | kr375.00k | no data | |
| Member of Scientific Advisory Board | 6.1yrs | no data | no data | |
| Member of Scientific Advisory Board | 6.1yrs | no data | no data | |
| Independent Director | 6.1yrs | kr375.00k | 0.46% SEK 9.5m | |
| Employee Representative Director | 9.3yrs | no data | 0.0014% SEK 29.4k | |
| Independent Director | 2.8yrs | kr395.00k | 0.023% SEK 472.4k | |
| Member of Scientific Advisory Board | 6.1yrs | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data |
5.6yrs
Average Tenure
63yo
Average Age
Experienced Board: BINVS's board of directors are considered experienced (5.6 years average tenure).